STERIS Return on Tangible Equity 2010-2022 | STE
Current and historical return on tangible equity values for STERIS (STE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| STERIS Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2022-09-30 |
$-0.01B |
$-0.97B |
0.69% |
| 2022-06-30 |
$0.38B |
$-1.10B |
-29.04% |
| 2022-03-31 |
$0.24B |
$-1.19B |
-16.69% |
| 2021-12-31 |
$0.28B |
$-1.37B |
-23.78% |
| 2021-09-30 |
$0.25B |
$-1.54B |
-29.27% |
| 2021-06-30 |
$0.29B |
$-1.75B |
-96.87% |
| 2021-03-31 |
$0.40B |
$-0.03B |
140.26% |
| 2020-12-31 |
$0.43B |
$-0.09B |
104.26% |
| 2020-09-30 |
$0.42B |
$0.69B |
78.70% |
| 2020-06-30 |
$0.41B |
$0.57B |
91.63% |
| 2020-03-31 |
$0.41B |
$0.50B |
106.53% |
| 2019-12-31 |
$0.39B |
$0.40B |
121.58% |
| 2019-09-30 |
$0.34B |
$0.34B |
126.55% |
| 2019-06-30 |
$0.32B |
$0.30B |
152.15% |
| 2019-03-31 |
$0.30B |
$0.26B |
199.34% |
| 2018-12-31 |
$0.27B |
$0.17B |
264.37% |
| 2018-09-30 |
$0.32B |
$0.12B |
495.69% |
| 2018-06-30 |
$0.30B |
$0.07B |
1361.80% |
| 2018-03-31 |
$0.29B |
$0.06B |
-1337.93% |
| 2017-12-31 |
$0.24B |
$0.02B |
-335.17% |
| 2017-09-30 |
$0.14B |
$-0.05B |
-119.92% |
| 2017-06-30 |
$0.12B |
$-0.11B |
-79.47% |
| 2017-03-31 |
$0.11B |
$-0.15B |
-62.29% |
| 2016-12-31 |
$0.14B |
$-0.17B |
-70.94% |
| 2016-09-30 |
$0.17B |
$-0.17B |
-70.49% |
| 2016-06-30 |
$0.14B |
$-0.21B |
-71.71% |
| 2016-03-31 |
$0.11B |
$-0.24B |
-121.98% |
| 2015-12-31 |
$0.09B |
$-0.32B |
417.78% |
| 2015-09-30 |
$0.11B |
$0.02B |
71.79% |
| 2015-06-30 |
$0.13B |
$0.18B |
66.50% |
| 2015-03-31 |
$0.14B |
$0.21B |
67.25% |
| 2014-12-31 |
$0.13B |
$0.22B |
60.18% |
| 2014-09-30 |
$0.12B |
$0.20B |
50.72% |
| 2014-06-30 |
$0.12B |
$0.18B |
45.94% |
| 2014-03-31 |
$0.13B |
$0.29B |
44.56% |
| 2013-12-31 |
$0.13B |
$0.31B |
47.31% |
| 2013-09-30 |
$0.15B |
$0.29B |
59.39% |
| 2013-06-30 |
$0.16B |
$0.27B |
63.01% |
| 2013-03-31 |
$0.16B |
$0.24B |
50.80% |
| 2012-12-31 |
$0.16B |
$0.21B |
43.37% |
| 2012-09-30 |
$0.15B |
$0.30B |
34.20% |
| 2012-06-30 |
$0.14B |
$0.50B |
29.42% |
| 2012-03-31 |
$0.14B |
$0.49B |
29.69% |
| 2011-12-31 |
$0.13B |
$0.45B |
28.84% |
| 2011-09-30 |
$0.12B |
$0.44B |
26.42% |
| 2011-06-30 |
$0.13B |
$0.47B |
28.05% |
| 2011-03-31 |
$0.05B |
$0.47B |
12.11% |
| 2010-12-31 |
$0.04B |
$0.43B |
10.14% |
| 2010-09-30 |
$0.06B |
$0.42B |
14.72% |
| 2010-06-30 |
$0.06B |
$0.39B |
13.25% |
| 2010-03-31 |
$0.13B |
$0.45B |
28.52% |
| 2009-12-31 |
$0.13B |
$0.42B |
28.65% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$19.157B |
$4.585B |
|
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
|
